Literature DB >> 24907118

Crosstalk between TGF-β1 and CXCR3 signaling during urethral fibrosis.

Hong Xie1, Chao Feng, Qiang Fu, Ying-Long Sa, Yue-Min Xu.   

Abstract

Urethral fibrosis is an important pathological feature of urethral stricture. TGF-β1 and CXC chemokine receptor 3 (CXCR3) signaling have been reported as the critical pathways involved in the pathology of fibrosis. Here, we collected the urine samples from the patients with recurring urethral stricture, recurring stricture treated by cystostomy, and age- and gender-matched healthy people. ELISA detection revealed that TGF-β1 level was significantly up-regulated for the urethral stricture patients. By contrast, flow cytometry, real-time PCR detection, and immunofluoresecent staining showed that urethral stricture resulted in decreased expression of CXCR3. TGF-β1 treatment could increase cell proliferation and migration ability of urethra fibroblasts, whereas IP-10/CXCR3 signaling showed the opposite effect. Further, we found a crosstalk between TGF-β1 and CXCR3 signaling in the regulation of urethral fibrosis. Thus, pharmacological intervention of TGF-β1 or CXCR3 signaling has a potential as the therapeutic target for the prevention of urethral fibrosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24907118     DOI: 10.1007/s11010-014-2104-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring.

Authors:  Cecelia C Yates; Priya Krishna; Diana Whaley; Richard Bodnar; Timothy Turner; Alan Wells
Journal:  Am J Pathol       Date:  2010-03-04       Impact factor: 4.307

Review 2.  Management of distal anterior urethral strictures.

Authors:  Jeremy B Tonkin; Gerald H Jordan
Journal:  Nat Rev Urol       Date:  2009-09-08       Impact factor: 14.432

3.  The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions.

Authors:  Valerie Booth; David W Keizer; Monique B Kamphuis; Ian Clark-Lewis; Brian D Sykes
Journal:  Biochemistry       Date:  2002-08-20       Impact factor: 3.162

4.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3.

Authors:  Dianhua Jiang; Jiurong Liang; Jennifer Hodge; Bao Lu; Zhou Zhu; Shuang Yu; Juan Fan; Yunfei Gao; Zhinan Yin; Robert Homer; Craig Gerard; Paul W Noble
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  Etiology of urethral stricture disease in the 21st century.

Authors:  Nicolaas Lumen; Piet Hoebeke; Pieter Willemsen; Bart De Troyer; Ronny Pieters; Willem Oosterlinck
Journal:  J Urol       Date:  2009-07-18       Impact factor: 7.450

6.  Extracellular matrix changes in urethral stricture disease.

Authors:  E Alexsandro Da-Silva; Francisco J B Sampaio; M Cristina Dornas; Ronaldo Damiao; Luiz E M Cardoso
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

Review 7.  TGF-beta and fibrosis in different organs - molecular pathway imprints.

Authors:  Dirk Pohlers; Julia Brenmoehl; Ivonne Löffler; Cornelia K Müller; Carola Leipner; Stefan Schultze-Mosgau; Andreas Stallmach; Raimund W Kinne; Gunter Wolf
Journal:  Biochim Biophys Acta       Date:  2009-06-17

8.  Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

Authors:  Marija Zeremski; Lydia M Petrovic; Luis Chiriboga; Queenie B Brown; Herman T Yee; Milan Kinkhabwala; Ira M Jacobson; Rositsa Dimova; Marianthi Markatou; Andrew H Talal
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 9.  Novel functions of vimentin in cell adhesion, migration, and signaling.

Authors:  Johanna Ivaska; Hanna-Mari Pallari; Jonna Nevo; John E Eriksson
Journal:  Exp Cell Res       Date:  2007-04-14       Impact factor: 3.905

10.  The use of halofuginone in limiting urethral stricture formation and recurrence: an experimental study in rabbits.

Authors:  Mehdi Jaidane; Bedeir Ali-El-Dein; Abdelahad Ounaies; Ashraf T Hafez; Tarek Mohsen; Mahmoud Bazeed
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

View more
  10 in total

Review 1.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

2.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07

3.  Exploring Relevant mRNAs and miRNAs in Injured Urethral Tissues of Rats with High-Throughput Sequencing.

Authors:  Han Lin; Shiyong Guo; Song Li; Jihong Shen; Jianfeng He; Yun Zheng; Zhenhua Gao
Journal:  Genes (Basel)       Date:  2022-05-05       Impact factor: 4.141

Review 4.  Regenerative and engineered options for urethroplasty.

Authors:  Filippo Pederzoli; Gregory Joice; Andrea Salonia; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Nat Rev Urol       Date:  2019-06-06       Impact factor: 14.432

5.  Rapamycin Inhibits the Growth and Collagen Production of Fibroblasts Derived from Human Urethral Scar Tissue.

Authors:  Delai Fu; Jian Yin; Shanlong Huang; Hecheng Li; Zhaolun Li; Tie Chong
Journal:  Biomed Res Int       Date:  2018-04-17       Impact factor: 3.411

Review 6.  Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19.

Authors:  Dana R Julian; Megan A Kazakoff; Akhil Patel; Jesse Jaynes; Monte S Willis; Cecelia C Yates
Journal:  Curr Pathobiol Rep       Date:  2021-12-08

7.  Circ_0047339 promotes the activation of fibroblasts and affects the development of urethral stricture by targeting the miR-4691-5p/TSP-1 axis.

Authors:  Ke Ding; Daoyuan Li; Rui Zhang; Meilin Zuo
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

8.  Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study.

Authors:  Kaile Zhang; Xuran Guo; Weixin Zhao; Guoguang Niu; Xiumei Mo; Qiang Fu
Journal:  Int J Mol Sci       Date:  2015-11-19       Impact factor: 5.923

9.  Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases.

Authors:  Morgan K Groover; Jillian M Richmond
Journal:  F1000Res       Date:  2020-10-05

10.  Effects of a gamma-secretase inhibitor of notch signalling on transforming growth factor β1-induced urethral fibrosis.

Authors:  Shanlong Huang; Delai Fu; Ziyan Wan; Min Li; Hecheng Li; Tie Chong
Journal:  J Cell Mol Med       Date:  2021-08-06       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.